New diarylheptanoid dimers as GLP-1 secretagogues and multiple-enzyme inhibitors from Alpinia katsumadai

Abstract

Ten new diarylheptanoid dimers, katsumadainols C₁ - C₁₀ (1-10), were isolated from the seeds of Alpinia katsumada and elucidated by extensive spectroscopic methods, ECD calculations, and single-crystal X-ray diffraction. Their antidiabetic effects were evaluated by the stimulation of GLP-1 secretion in STC-1 cells and inhibition against four diabetes-related enzymes, GPa, α-glucosidase, PTP1B, and DPP4. Compounds 1-5 and 7-10 significantly stimulated GLP-1 secretion by 267.5-433.1% (25.0 μM) and 117.8-348.2% (12.5 μM). Compounds 1-4 exhibited significant inhibition on GPa with IC₅₀ values of 18.0-31.3 μM; compounds 1-5 showed obvious inhibition on α-glucosidase with IC₅₀ values of 6.9-18.2 μM; compounds 1-5 and 10 possessed PTP1B inhibitory activity with IC₅₀ values ranging from 35.5 to 80.1 μM. This investigation first disclosed compounds 1-4 as intriguing GLP-1 secretagogues and GPa, α-glucosidase, and PTP1B inhibitors, which provided valuable clues for searching multiple-target antidiabetic candidates from Zingiberaceae plants.

Keywords: Alpinia katsumadai; Diarylheptanoid dimers; Enzyme inhibitors; GLP-1 secretagogues; Katsumadainols C(1)−C(10); Multiple-target antidiabetic agents.